Choices Among Immunotherapeutics May Be the Future of Lung Cancer Care episode artwork

EPISODE · Jun 25, 2015 · 6 MIN

Choices Among Immunotherapeutics May Be the Future of Lung Cancer Care

from GRACEcast · host cancerGRACE Meetings

Novel immunotherapy agent atezolizumab (MPDL3280A) looks superior to Taxotere (docetaxel) in a study, specifically for patients with PD-L1. What are the implications of multiple agents with similar mechanisms of action in the same clinical settings?

Episode metadata supplied by the publisher feed · Published Jun 25, 2015

Embed this episode

NOW PLAYING

Choices Among Immunotherapeutics May Be the Future of Lung Cancer Care

0:00 6:02

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of GRACEcast?

This episode is 6 minutes long.

When was this GRACEcast episode published?

This episode was published on June 25, 2015.

Can I download this GRACEcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!